Year

2014
Veloxis Pharmaceuticals A/S (OMX: VELO) announced today that it has filed an action in federal district court for the District of Columbia against the Food and Drug Administration, seeking an order requiring FDA to grant final approval to Envarsus® XR.
Trial using Nexstim's Navigated Brain Therapy (NBT®) system for pain relief in patients suffering from chronicneuropathic painSecond study using Nexstim's technology at The Walton Centre, the only specialist neuroscience centre in the NHS, to show long term effect of NBT®Previous study demonstrated 44% of patients obtained clinically meaningful pain relief of at least 3 weeks'...
BONESUPPORT and Orthocell agreement to facilitate:Partnership to co-develop bone repair products utilizing the unique eluting bone remodelling capabilities of CERAMENTT and the important collagen properties of CelgroTOrthocell and BONESUPPORT to co-develop CelgroT collagen scaffold to create next generation bone repair product that also induces bone growth
Foredragsholdere: Videnskabsjournalist Lone Frank og professor i antropologi Andreas Roepstorff, Aarhus Universitet Hvor meget er vores personlighed bestemt af gener? Kan vi forstå os selv og andre bedre ved at kende til vores gensammensætning? Og kan indsigten gøre os til bedre og mere lykkelige mennesker? I filmen ’Genetic Me’ undersøger videnskabsjournalist Lone Frank, hvordan udbredelsen...
CANTERBURY, UK, Dec. 1, 2014 (GLOBE NEWSWIRE) -- Ziarco Group Ltd., a biopharmaceutical company focusing on inflammatory skin diseases, today announced the addition of Mike Grey to its Board of Directors as an independent director. Mr. Grey is Chairman and Chief Executive Officer (CEO) of Reneo Pharmaceuticals, a privately held biotechnology company, and a Venture...
LEXINGTON, Mass., December 2, 2014 /PRNewswire/ -- scPharmaceuticals, Inc., a privately held biopharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery, announced today that Leonard D. Schaeffer has been appointed to scPharmaceutical's board of directors.
Foredragsholdere: Lundbeckfond fellow, forskningslektor i partikelfysik Troels Petersen, Københavns Universitet, professor i geologi Minik Rosing, Københavns Universitet, og Lundbeckfond professor i geogenitik Eske Willerslev, Statens Naturhistoriske Museum I den mest kendte scene fra Stanley Kubricks ’Rumrejsen år 2001’, klippes der fra en forhistorisk abe der slynger en knogle i luften, til et rumskib, som poetisk...
Foredragsholdere: Lundbeckfond fellow, forskningslektor i partikelfysik Troels Petersen, Københavns Universitet, professor i geologi Minik Rosing, Københavns Universitet, og Lundbeckfond professor i geogenitik Eske Willerslev, Statens Naturhistoriske Museum I den mest kendte scene fra Stanley Kubricks ’Rumrejsen år 2001’, klippes der fra en forhistorisk abe der slynger en knogle i luften, til et rumskib, som poetisk...
Collaboration to generate novel diagnostic products to support personalized therapies for microbiome-related diseases
Foredragsholdere: Lundbeckfond fellow, professor Thomas Lars Andresen, DTU og professor, overlæge Andreas Kjær, Rigshospitalet og Københavns Universitet Kræftforskningen bevæger sig i disse år ned på et mikroskopisk plan. Nanoteknologi kan vise sig at være en effektiv metode til at få bugt med flere forskellige kræftformer. To af Danmarks førende forskere på området vil fortælle om,...
1 2 3 12

Nyheder

Ny analysemetode afslører kroppens politimænd
19. november 2018
Verdens eneste terningformede lort kan nu forklares videnskabeligt
19. november 2018
Genetisk hurtigløb – hele vejen ned gennem det amerikanske kontinent
9. november 2018

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge